Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Childhood Absence Epilepsy
NCT00210574Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Mar 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of topiramate in childhood absence epilepsy (CAE), sponsored by Johnson & Johnson. Started Mar 2005; status: completed.
02
Drugs
topiramate
03
Conditions
childhood absence epilepsy (CAE)
Beyond the preview
Go deeper on NCT00210574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210574.